Clinical trial Recruiting at 1 site Interventional Ages 21 to 99

Early activation and sleep-promoting routines to reduce delirium after CABG

Official title: DREAMS-OT Trial: Delirium Reduction Through Early Activation in Motivating and Sleep Promoting Routines: A Randomized Controlled Trial of Occupational Therapy for ICU Patients After Coronary Artery Bypass Graft (CABG) Surgery

Run by National University Hospital, Singapore · NCT06107517 · Data updated 2026-11-12

We will test whether early occupational therapy combined with sleep-promoting routines (DREAMS-OT) can reduce delirium in adults undergoing elective CABG surgery.

More Delirium - Postoperative trials

Quick facts

Study typeInterventional
Ages21 Years to 99 Years
SexAll
Enrollment300 (estimated)
SponsorNational University Hospital, Singapore
Academic / other
Locations1 site (Singapore)
StatusRecruiting
StartedJanuary 8, 2024
Main results expectedAugust 2026
Study endsAugust 2026
Registry record updatedMarch 30, 2026
Trial IDNCT06107517 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults (≥21) scheduled for elective CABG at National University Hospital who can provide consent and communicate in English or Mandarin and do not have severe preexisting cognitive or hearing impairments.

Probably not a fit

Patients who develop delirium before treatment begins, those with progressive neurological disorders, severe cognitive or hearing impairment, or pregnant women are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will compare the DREAMS-OT program—early, intensive occupational therapy plus structured sleep-promoting routines—to standard post-CABG care. Adults aged 21 and over scheduled for elective CABG at National University Hospital Singapore who can consent and speak English or Mandarin will be enrolled and randomized to intervention or control. The primary outcome is the incidence of postoperative delirium within five days after surgery, and the study will also evaluate the cost-effectiveness of the intervention. Patients with severe preexisting cognitive or sensory impairments, those who develop delirium before the intervention, or those with unstable surgical complications are excluded.

Why it matters

Potential benefit: If successful, DREAMS-OT could lower the number of patients who develop delirium after CABG and may reduce ICU and hospital length of stay.

How similar studies have gone: Multicomponent programs including early mobilization and sleep protocols have reduced delirium in older surgical and ICU patients, but occupational-therapy–focused interventions specifically for post-CABG patients have been less extensively studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients deemed medically suitable for elective CABG surgery
* Patients aged 21 years and above
* Patients who are English or Mandarin speaking.
* Patients who are able to provide consent

Exclusion Criteria:

* Patients who speak other languages are excluded due to the language requirements of certain outcome measures.
* Patients with premorbid severe hearing impairment, severe cognitive impairment, progressive neurological disorders and psychological disorders will be excluded.
* Patients with surgical complications resulting in profuse bleeding from any invasive sites, septic shock unresponsive to maximal treatment, and those who are moribund or have an expected mortality within 48 hours will be excluded.
* Pregnant women will also be excluded from the study as well.
* Patients who develop delirium before initiation of the treatment are also excluded from the study.

Where it's running

  • National University Hospital
    Singapore, Singapore
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.